C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7700620B2 · kind B2 · utility
20Cited by
25References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2006 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Feb 7, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel C-linked cyclic compounds and analogues of Formula (I):or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, D and W are as defined herein. These compounds are selective inhibitors of the human P2Y1 receptor which can be used as medicaments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.